Poller W, Faber J P, Olek K
Medizinische Klinik und Poliklinik, Klinikum Bergmannsheil, Ruhr-Universität Bochum.
Klin Wochenschr. 1990 Sep 3;68(17):857-63. doi: 10.1007/BF01662782.
Among 20 individuals with severe alpha 1-antitrypsin (alpha 1AT) deficiency we observed extremely variable clinical phenotypes ranging from rapidly progressive lung disease fatal at the age of 42 years to an asymptomatic individual with normal lung function at the age of 50 years. Eighteen subjects, including the asymptomatic one, carried the deficient Pi ZZ phenotype as determined by isoelectric focusing (IEF). Their mean alpha 1AT serum level was 36.7 +/- 7.7 mg/dl. DNA restriction analysis showed that all of them had the classical Pi Z-allele-associated DNA haplotype, thus confirming the IEF data. Obviously not all Pi ZZ individuals will have clinical sequelae caused by this genotype. The important differences in clinical course observed could not be explained by smoking habits alone. Probably additional factors are pertinent to the pathogenesis of the lung disease associated with alpha 1AT deficiency (defects in other genes, environmental influences other than smoking). In two patients with very low alpha 1AT serum levels definitive phenotyping by IEF was not possible. Therefore we investigated the molecular basis of their deficiency using polymerase chain reaction (PCR) amplification of the coding exons of their alpha 1AT genes and direct sequencing of the amplification products. Sequence data analysis showed that one of these patients, who had initially been phenotyped as Pi ZZ by IEF, had in fact the genotype Pi QObellinghamZ, thus explaining her low alpha 1AT serum level of 20 mg/dl. The other patient (alpha 1AT serum level 3.7 mg/dl) exhibited the rare genotype Pi MheerlenQOgranite falls. Despite his nearly complete alpha 1AT deficiency, he suffered from only moderately severe pulmonary disease at the age of 42 years.
在20名严重α1-抗胰蛋白酶(α1AT)缺乏症患者中,我们观察到了极为多样的临床表型,从42岁时死于快速进展性肺病到50岁时肺功能正常的无症状个体。通过等电聚焦(IEF)测定,包括无症状个体在内的18名受试者携带缺陷型Pi ZZ表型。他们的α1AT血清平均水平为36.7±7.7mg/dl。DNA限制性分析表明,他们所有人都具有与经典Pi Z等位基因相关的DNA单倍型,从而证实了IEF数据。显然,并非所有Pi ZZ个体都会出现由这种基因型引起的临床后遗症。观察到的临床病程中的重要差异不能仅用吸烟习惯来解释。可能还有其他因素与α1AT缺乏症相关的肺病发病机制有关(其他基因的缺陷、吸烟以外的环境影响)。在两名α1AT血清水平极低的患者中,无法通过IEF进行明确的表型分析。因此,我们使用聚合酶链反应(PCR)扩增他们α1AT基因的编码外显子并对扩增产物进行直接测序,来研究其缺乏症的分子基础。序列数据分析表明,其中一名最初通过IEF被表型鉴定为Pi ZZ的患者,实际上具有Pi QObellinghamZ基因型,这就解释了她20mg/dl的低α1AT血清水平。另一名患者(α1AT血清水平3.7mg/dl)表现出罕见的Pi MheerlenQOgranite falls基因型。尽管他几乎完全缺乏α1AT,但在42岁时仅患有中度严重的肺部疾病。